VMA21 antibody (N-Term)
Quick Overview for VMA21 antibody (N-Term) (ABIN205060)
Target
See all VMA21 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Human VMA21
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%) Mouse, Rat, Rabbit (92%) Bovine (91%) Dog (85%).
-
Purification
- Protein A purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human VMA21 (Q3ZAQ7, NP_001017980). Percent identity by BLAST analysis: Human, Chimpanzee, Orangutan, Gibbon, Monkey (100%), Marmoset, Mouse, Rat, Rabbit (92%), Bovine, Pig (91%), Hamster, Elephant, Panda, Dog (85%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P, WB (5 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- VMA21 (Vacuolar H+-ATPase Homolog (VMA21))
-
Alternative Name
- VMA21 / XMEA
-
Background
-
Name/Gene ID: VMA21
Synonyms: VMA21, MEAX, XMEA -
Gene ID
- 203547
-
NCBI Accession
- NP_001017980
-
UniProt
- Q3ZAQ7
Target
-